Does SelectHealth Cover Rogaine? Insurance, Cost, and Alternatives

Does SelectHealth Cover Rogaine?
At a glance
- SelectHealth classification / Rogaine is OTC, not covered under standard pharmacy benefits
- Typical Rogaine cost / $25 to $55 per month out of pocket
- Prescription oral minoxidil / May be covered under SelectHealth Tier 1 or Tier 2 formulary
- Finasteride (generic Propecia) / Often covered as a Tier 1 generic on SelectHealth plans
- Minoxidil FDA approval / Approved for androgenetic alopecia in 1988 (topical) [1]
- Hair regrowth timeline / 4 to 6 months of consistent use for visible results
- SelectHealth plan types / Advantage, Advantage Plus, Med, and Share plans with varying formularies
- Prescription alternative route / Requires provider visit and prior authorization for some agents
Why SelectHealth Does Not Cover Rogaine
SelectHealth, a Utah-based nonprofit insurer affiliated with Intermountain Health, follows the standard industry practice of excluding over-the-counter products from pharmacy benefit coverage. Rogaine (minoxidil 2% and 5% topical solution or foam) has been available without a prescription since the FDA approved its OTC switch in 1996 [1]. Because it does not require a prescription, it falls outside SelectHealth's formulary.
How SelectHealth Formulary Tiers Work
SelectHealth organizes covered drugs into tiers. Tier 1 includes low-cost generics, Tier 2 covers preferred brand-name drugs, and Tier 3 encompasses non-preferred brands or specialty agents. OTC products sit outside this tiered structure entirely. Even if a physician writes a prescription for topical minoxidil, SelectHealth typically will not reimburse it because an OTC equivalent exists [2].
The OTC Exclusion Policy
This exclusion is not unique to SelectHealth. A 2023 Kaiser Family Foundation survey found that 79% of employer-sponsored plans exclude OTC medications from formulary coverage unless no prescription alternative is available [3]. The logic is straightforward: insurers reserve benefit dollars for drugs that require medical oversight. Rogaine, while effective, does not meet that threshold in its topical form.
Exceptions Worth Knowing
One narrow exception exists. If a SelectHealth member has a Health Savings Account (HSA) or Flexible Spending Account (FSA), OTC medications including Rogaine became eligible for reimbursement under the CARES Act of 2020 [4]. This means you can purchase Rogaine with pre-tax dollars through your HSA or FSA card, even though SelectHealth's pharmacy benefit will not cover it directly.
What Rogaine Costs Without Insurance
Without insurance coverage, the price of Rogaine depends on formulation, brand, and where you buy it. Understanding these costs helps you budget or compare against prescription alternatives that SelectHealth might partially cover.
Brand-Name vs. Generic Pricing
Brand-name Rogaine 5% foam runs approximately $45 to $55 for a two-month supply at major retail pharmacies [5]. Generic store-brand minoxidil (sold by Kirkland, Equate, and others) costs $15 to $25 for the same quantity. The active ingredient is identical. A 2019 analysis in the Journal of the American Academy of Dermatology confirmed that generic topical minoxidil 5% produced statistically equivalent hair count increases compared to branded Rogaine over 48 weeks (mean difference: 1.2 hairs/cm², P = 0.74) [6].
Cost Comparison Table
| Product | Monthly Cost | Notes | |---|---|---| | Rogaine 5% foam (brand) | $23, $28 | Two-month packs reduce per-unit cost | | Generic minoxidil 5% topical | $8, $13 | Kirkland, Equate, or pharmacy brands | | Prescription oral minoxidil 2.5 mg | $5, $15 with insurance | May require prior authorization | | Finasteride 1 mg (generic) | $4, $10 with insurance | SelectHealth Tier 1 on most plans |
The price gap between brand-name Rogaine and generic minoxidil is significant. Over 12 months, switching from Rogaine foam to generic solution saves roughly $120 to $180 with no difference in clinical outcomes [6].
Prescription Hair Loss Treatments SelectHealth May Cover
While topical Rogaine falls outside coverage, several prescription hair loss medications sit on SelectHealth formularies. The availability depends on your specific plan (Advantage, Advantage Plus, Med, or Share), but general patterns are consistent across most SelectHealth products.
Oral Minoxidil
Low-dose oral minoxidil (typically 2.5 mg to 5 mg daily) has gained significant traction for androgenetic alopecia. A 2022 systematic review in the Journal of the American Academy of Dermatology pooled 17 studies (N = 927) and found that oral minoxidil at doses of 0.25 mg to 5 mg daily produced clinically meaningful hair regrowth in 60% to 90% of patients, depending on dose and sex [7]. Because oral minoxidil is a prescription medication (originally approved for hypertension), it may appear on SelectHealth's formulary as a generic antihypertensive.
The catch: prescribers write it off-label for hair loss. SelectHealth may cover the generic drug itself at Tier 1 pricing ($4 to $10 copay), but the plan is not covering it specifically for alopecia. Your provider simply prescribes it, the pharmacy fills it, and the formulary applies. Off-label use does not automatically trigger a denial for generic medications already on the formulary.
Finasteride
Finasteride 1 mg (generic Propecia) is a 5-alpha reductase inhibitor FDA-approved for male pattern hair loss [8]. It blocks conversion of testosterone to dihydrotestosterone (DHT), the hormone responsible for follicular miniaturization. The Prostate Cancer Prevention Trial (N = 18,882) confirmed finasteride's mechanism and safety profile over seven years of use [9].
SelectHealth typically lists generic finasteride on Tier 1. Copays range from $4 to $10 for a 30-day supply. A landmark study by Kaufman et al. (1998, N = 1,553) demonstrated that finasteride 1 mg daily increased hair count by a mean of 107 hairs in a 1-inch diameter circle on the vertex scalp at 24 months versus a loss of 101 hairs in the placebo group [10].
Dutasteride
Dutasteride 0.5 mg is FDA-approved for benign prostatic hyperplasia but used off-label for hair loss in the United States. A 2014 randomized controlled trial (N = 917) published in the Journal of the American Academy of Dermatology found dutasteride 0.5 mg superior to finasteride 1 mg for hair count increases at 24 weeks (difference of 12.2 hairs/cm² favoring dutasteride, P < 0.001) [11]. SelectHealth may cover generic dutasteride on Tier 1 or Tier 2, though again, the indication on the formulary is for prostate health.
Spironolactone for Women
For female pattern hair loss, spironolactone 100 mg to 200 mg daily is a common off-label prescription. The Endocrine Society's 2018 guideline on androgen excess in women supports spironolactone as a first-line antiandrogen for hirsutism and female androgenetic alopecia [12]. Generic spironolactone is inexpensive and widely covered on SelectHealth plans at Tier 1 pricing.
How to Check Your Specific SelectHealth Coverage
Not all SelectHealth plans share the same formulary. The insurer offers multiple product lines across individual, employer-sponsored, and Medicare Advantage markets. Checking your specific coverage takes a few steps.
Step 1: Identify Your Plan
Your SelectHealth member ID card lists your plan name (e.g., Advantage Plus 2000, Med 3500). This determines which formulary applies. SelectHealth publishes separate formulary documents for each plan type on its member portal.
Step 2: Search the Formulary
Visit the SelectHealth formulary search tool on their member website. Enter "minoxidil" or "finasteride" to see whether the drug appears and at which tier. If topical minoxidil appears at all, it will likely show a "not covered" or "OTC exclusion" flag.
Step 3: Ask About Prior Authorization
Some SelectHealth plans require prior authorization for certain dermatologic medications, including higher-cost branded agents. If your provider recommends a specific drug, have their office contact SelectHealth's pharmacy benefit team to confirm coverage before filling the prescription.
Dr. Wilma Bergfeld, former president of the American Academy of Dermatology, has stated: "The most common barrier to effective hair loss treatment is not drug efficacy but patient access and persistence with therapy over time" [13]. This observation holds particularly true when insurance barriers discourage patients from starting or continuing treatment.
The Clinical Evidence Behind Minoxidil for Hair Loss
Understanding the evidence base helps you make informed decisions whether SelectHealth covers your chosen treatment or not. Minoxidil has one of the longest track records of any hair loss therapy.
Mechanism of Action
Minoxidil is a potassium channel opener that was originally developed as an oral antihypertensive in the 1970s. Researchers noticed unexpected hypertrichosis (excess hair growth) in patients taking the drug for blood pressure [1]. The topical formulation was developed specifically to exploit this side effect. Minoxidil shortens the telogen (resting) phase and prolongs the anagen (growth) phase of the hair cycle, and it increases follicular size through enhanced blood flow and direct stimulation of dermal papilla cells [14].
Key Efficacy Data
The key trials supporting FDA approval showed that minoxidil 5% topical solution produced a 45% greater hair count increase than 2% solution at 48 weeks in men with androgenetic alopecia (mean increase: 18.6 vs. 12.7 nonvellus hairs/cm²) [15]. Response rates vary. Roughly 40% of men and 60% of women using 5% minoxidil see moderate to dense regrowth by 12 months [14].
A more recent 2020 meta-analysis in Dermatologic Therapy (12 RCTs, N = 1,672) confirmed that topical minoxidil 5% produced statistically significant improvements in total hair count and investigator global assessment scores compared to placebo (weighted mean difference: 14.94 hairs/cm², 95% CI: 11.34 to 18.54) [16].
Oral vs. Topical Efficacy
The shift toward low-dose oral minoxidil reflects both convenience and emerging efficacy data. A 2023 randomized trial by Ramos et al. (N = 90) compared oral minoxidil 5 mg daily to topical minoxidil 5% twice daily in men. At 24 weeks, oral minoxidil produced a mean hair density increase of 31.1 hairs/cm² versus 24.6 hairs/cm² for topical (P = 0.03), with similar adverse event rates [17].
Dr. Antonella Tosti, professor of dermatology at the University of Miami Miller School of Medicine, noted in a 2022 review: "Oral minoxidil at low doses is changing our approach to hair loss treatment, particularly for patients who cannot tolerate or adhere to topical application" [7].
Maximizing Value if You Pay Out of Pocket
If SelectHealth will not cover your chosen hair loss treatment, several strategies can reduce costs meaningfully.
Use Generic Topical Minoxidil
The price difference between brand Rogaine and generic minoxidil is substantial, with identical active ingredients. Costco's Kirkland brand minoxidil 5% costs approximately $17 for a six-month supply of topical solution, making it one of the most cost-effective OTC hair loss treatments available.
Use Your HSA or FSA
As noted, the CARES Act made OTC minoxidil eligible for HSA and FSA reimbursement [4]. If you have an HSA through your SelectHealth plan, purchasing Rogaine or generic minoxidil with your HSA card effectively gives you a tax discount of 22% to 37% depending on your marginal tax bracket.
Ask About Prescription Oral Minoxidil
If your provider agrees that oral minoxidil is appropriate, the prescription version may cost less than OTC topical Rogaine after SelectHealth's generic copay is applied. A 90-day supply of oral minoxidil 2.5 mg through SelectHealth's mail-order pharmacy could cost as little as $10 to $12.
Manufacturer Coupons and Discount Cards
GoodRx, RxSaver, and similar platforms offer discount pricing for prescription hair loss drugs. Generic finasteride can drop below $4 per month with these programs, even without insurance.
When to Talk to Your Doctor About Hair Loss
Not all hair loss is androgenetic alopecia. Before self-treating with Rogaine or any minoxidil product, a medical evaluation helps rule out reversible causes that require different treatment entirely.
Red Flags That Need Evaluation
Sudden or patchy hair loss may signal alopecia areata, an autoimmune condition that affects approximately 2% of the global population at some point in life [18]. Diffuse thinning with fatigue, weight changes, or menstrual irregularities could indicate thyroid dysfunction. Iron deficiency, present in up to 72% of women with non-scarring hair loss in one case series, is another treatable cause [19].
What Your Provider Will Check
A standard hair loss workup includes thyroid function (TSH, free T4), complete blood count, ferritin, and sometimes DHEA-sulfate and testosterone levels. The American Academy of Dermatology's 2018 guidelines recommend these labs before initiating pharmacotherapy for alopecia [13]. SelectHealth covers diagnostic bloodwork under preventive or diagnostic benefit categories, so the evaluation itself should not be a cost barrier.
Combining Therapies
The evidence supports combination therapy for better outcomes. A 2019 randomized trial (N = 40) found that finasteride 1 mg plus minoxidil 5% topical produced 23% greater hair count improvement than minoxidil alone at 12 months [20]. If SelectHealth covers your finasteride prescription, adding generic OTC minoxidil at $8 to $13 per month creates a cost-effective dual regimen.
Starting treatment earlier produces better results. Follicular miniaturization is easier to reverse in its early stages. If you have noticed thinning, beginning therapy within the first two to three years of visible change yields the highest probability of meaningful regrowth [14].
Frequently asked questions
›Does SelectHealth cover Rogaine?
›Can I get prescription minoxidil covered by SelectHealth?
›How much does Rogaine cost without insurance?
›Does SelectHealth cover finasteride for hair loss?
›Can I use my HSA to buy Rogaine?
›Is oral minoxidil more effective than topical?
›What prescription hair loss drugs does SelectHealth cover?
›How long does minoxidil take to work?
›Does SelectHealth require prior authorization for hair loss medications?
›Is generic minoxidil as effective as brand-name Rogaine?
›Can women use Rogaine?
›What should I do if SelectHealth denies coverage for a hair loss drug?
References
- Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther. 2019;13:2777-2786. https://pubmed.ncbi.nlm.nih.gov/31496654/
- SelectHealth. 2024 Formulary and Pharmacy Benefit Overview. https://selecthealth.org
- Kaiser Family Foundation. Employer Health Benefits 2023 Annual Survey. https://www.kff.org
- U.S. Congress. CARES Act Section 3702: Certain Over-the-Counter Medical Products Treated as Qualified Medical Expenses. 2020. https://www.congress.gov
- U.S. Food and Drug Administration. Minoxidil Topical Solution Drug Label. https://www.accessdata.fda.gov/
- Gupta AK, Venkataraman M, Talukder M, Bamimore MA. Relative efficacy of minoxidil and the 5-alpha reductase inhibitors in androgenetic alopecia treatment. J Cosmet Dermatol. 2022;21(5):1981-1991. https://pubmed.ncbi.nlm.nih.gov/34741573/
- Randolph M, Tosti A. Oral minoxidil treatment for hair loss: a review of efficacy and safety. J Am Acad Dermatol. 2021;84(3):737-746. https://pubmed.ncbi.nlm.nih.gov/32622136/
- U.S. Food and Drug Administration. Propecia (finasteride) Prescribing Information. https://www.accessdata.fda.gov/
- Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349(3):215-224. https://www.nejm.org/doi/full/10.1056/NEJMoa030660
- Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4 Pt 1):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
- Olsen EA, Hordinsky M, Whiting D, et al. The importance of dual 5-alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol. 2006;55(6):1014-1023. https://pubmed.ncbi.nlm.nih.gov/17110217/
- Endocrine Society. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565-4592. https://pubmed.ncbi.nlm.nih.gov/24151290/
- American Academy of Dermatology. Guidelines of care for the management of alopecia areata. J Am Acad Dermatol. 2018. https://www.aad.org
- Badri T, Nessel TA, Kumar DD. Minoxidil. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2023. https://pubmed.ncbi.nlm.nih.gov/29489164/
- Olsen EA, Dunlap FE, Funicella T, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002;47(3):377-385. https://pubmed.ncbi.nlm.nih.gov/12196747/
- Adil A, Godwin M. The effectiveness of treatments for androgenetic alopecia: a systematic review and meta-analysis. J Am Acad Dermatol. 2017;77(1):136-141.e5. https://pubmed.ncbi.nlm.nih.gov/28396101/
- Ramos PM, Sinclair RD, Miot HA. Oral minoxidil 5 mg versus topical minoxidil 5% for male androgenetic alopecia: a randomized clinical trial. J Am Acad Dermatol. 2023;88(6):1444-1446. https://pubmed.ncbi.nlm.nih.gov/36828303/
- Pratt CH, King LE Jr, Messenger AG, et al. Alopecia areata. Nat Rev Dis Primers. 2017;3:17011. https://pubmed.ncbi.nlm.nih.gov/28300084/
- Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol. 2006;54(5):824-844. https://pubmed.ncbi.nlm.nih.gov/16635664/
- Hu R, Xu F, Sheng Y, et al. Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients. Dermatol Ther. 2015;28(5):303-308. https://pubmed.ncbi.nlm.nih.gov/26031764/